P938: CARFILZOMIB-LENALIDOMIDE-DEXAMETHASONE CONSOLIDATION IN MYELOMA PATIENTS WITH A POSITIVE FDG PET/CT AFTER UPFRONT AUTOLOGOUS STEM CELL TRANSPLANTATION: A PHASE II STUDY (CONPET)

• J. N. Nørgaard,
• N. Abildgaard,
• A. Lysén,
• G. Tsykunova,
• A. J. Vangsted,
• C. Joao,
• N. Remen,
• L. Osnes,
• J. P. Connelly,
• M.-E. R. Revheim,
• F. Schjesvold

Affiliations

J. N. Nørgaard

1 Oslo Myeloma Center, Department of Hematology, Oslo University Hospital

N. Abildgaard

4 Department of Hematology, Odense University Hospital

A. Lysén

1 Oslo Myeloma Center, Department of Hematology, Oslo University Hospital

G. Tsykunova

6 Division of Hematology, Haukeland University Hostpital, Bergen, Norway

A. J. Vangsted

7 Departmen of Hematology, Rigshospitalet, Copenhagen, Denmark

C. Joao

8 Department of Hematology, Champalimaud Centre for the Unknown, Lisboa, Portugal

N. Remen

1 Oslo Myeloma Center, Department of Hematology, Oslo University Hospital

L. Osnes

9 Department of Immunology

J. P. Connelly

10 Division for Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway

M.-E. R. Revheim

2 Institute of Clinical Medicine

F. Schjesvold

1 Oslo Myeloma Center, Department of Hematology, Oslo University Hospital